Literature DB >> 23592891

Safety and efficacy of trimodality therapy in patients undergoing extrapleural pneumonectomy.

Servet Bölükbas1.   

Abstract

Entities:  

Year:  2013        PMID： 23592891      PMCID： PMC3626976          DOI： 10.3978/j.issn.1000-9604.2013.02.04

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN： 1000-9604            Impact factor:   5.087


× No keyword cloud information.
  14 in total

1.  Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.

Authors:  Loïc Lang-Lazdunski; Andrea Bille; Rohit Lal; Paul Cane; Emma McLean; David Landau; Jeremy Steele; James Spicer
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

2.  Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma.

Authors:  Servet Bölükbas; Michael Eberlein; Joachim Schirren
Journal:  J Thorac Oncol       Date:  2012-05       Impact factor: 15.609

Review 3.  Advances in malignant mesothelioma.

Authors:  Bruce W S Robinson; Richard A Lake
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

Review 4.  Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma.

Authors:  David J Sugarbaker
Journal:  J Thorac Oncol       Date:  2006-02       Impact factor: 15.609

5.  Patterns of failure after trimodality therapy for malignant pleural mesothelioma.

Authors:  E H Baldini; A Recht; G M Strauss; M M DeCamp; S J Swanson; M J Liptay; S J Mentzer; D J Sugarbaker
Journal:  Ann Thorac Surg       Date:  1997-02       Impact factor: 4.330

6.  A survey of opinions and beliefs concerning surgery for malignant pleural mesothelioma amongst 802 members of the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Thoracic Surgeons (ESTS) and the Society of Thoracic Surgeons (STS).

Authors:  Tom Treasure; Eveline Internullo; Francesca Fiorentino; Dirk Van Raemdonck; Paul Van Schil; Malcolm Decamp; Douglas Wood; Martin Utley
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-03

7.  Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.

Authors:  Kenneth E Rosenzweig; Marjorie G Zauderer; Benjamin Laser; Lee M Krug; Ellen Yorke; Camelia S Sima; Andreas Rimner; Raja Flores; Valerie Rusch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-18       Impact factor: 7.038

8.  Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.

Authors:  Joseph S Friedberg; Melissa J Culligan; Rosemarie Mick; James Stevenson; Stephen M Hahn; Daniel Sterman; Salman Punekar; Eli Glatstein; Keith Cengel
Journal:  Ann Thorac Surg       Date:  2012-05       Impact factor: 4.330

9.  Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Ronald Feld; B C John Cho; Andrea Bezjak; Masaki Anraku; Ronald Burkes; Heidi Roberts; Ming S Tsao; Natasha Leighl; Shaf Keshavjee; Michael R Johnston
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

10.  Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.

Authors:  W Weder; R A Stahel; J Bernhard; S Bodis; P Vogt; P Ballabeni; D Lardinois; D Betticher; R Schmid; R Stupp; H B Ris; M Jermann; W Mingrone; A D Roth; A Spiliopoulos
Journal:  Ann Oncol       Date:  2007-04-11       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.